AR030382A1 - Formulacion oral de un inhibidor de ciclooxigenasa-2 de fusion rapida - Google Patents
Formulacion oral de un inhibidor de ciclooxigenasa-2 de fusion rapidaInfo
- Publication number
- AR030382A1 AR030382A1 ARP010103961A ARP010103961A AR030382A1 AR 030382 A1 AR030382 A1 AR 030382A1 AR P010103961 A ARP010103961 A AR P010103961A AR P010103961 A ARP010103961 A AR P010103961A AR 030382 A1 AR030382 A1 AR 030382A1
- Authority
- AR
- Argentina
- Prior art keywords
- drug
- agent
- inhibitor
- cyclloxygenasa
- granules
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Abstract
Se describe un proceso para preparar una composicion oral de fusion rápida de una droga inhibidora selectiva de cilooxigensasa-2, donde dicho proceso comprende (a) un paso de granulacion humeda de la droga, junto con un agente aglutinante que comprende un sacárido de alta moldeabilidad, y (b) un paso que consiste en mezclar un sacárido de baja moldeabilidad con la droga donde los pasos anteriormente mencionados (a) y (b) se llevan a cabo en cualquier orden o simultáneamente para causar la formacion de gránulos. El proceso opcionalmente incorpora medios para inhibir la aglomeracion de la droga, por ejemplo la adicion de un agente de humedecimiento. Opcionalmente el proceso comprende además (c) un paso de mezclar los gránulos con por lo menos uno de un lubricante, un agente edulcorante y un agente saborizante para hacer una mezcla para formar tabletas, y (d) un paso de compresion de la mezcla para formar las tabletas orales de fusion rápida. También se proporciona una composicion preparada mediante un proceso con esas características.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22634900P | 2000-08-18 | 2000-08-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR030382A1 true AR030382A1 (es) | 2003-08-20 |
Family
ID=37515865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010103961A AR030382A1 (es) | 2000-08-18 | 2001-08-17 | Formulacion oral de un inhibidor de ciclooxigenasa-2 de fusion rapida |
Country Status (4)
Country | Link |
---|---|
US (1) | US20020119193A1 (es) |
AR (1) | AR030382A1 (es) |
PE (1) | PE20020322A1 (es) |
TW (1) | TWI256305B (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19940740A1 (de) * | 1999-08-31 | 2001-03-01 | Gruenenthal Gmbh | Pharmazeutische Salze |
US7927613B2 (en) * | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
US7790905B2 (en) * | 2002-02-15 | 2010-09-07 | Mcneil-Ppc, Inc. | Pharmaceutical propylene glycol solvate compositions |
US20050025791A1 (en) * | 2002-06-21 | 2005-02-03 | Julius Remenar | Pharmaceutical compositions with improved dissolution |
AU2003213719A1 (en) | 2002-03-01 | 2003-09-16 | Regents Of The University Of Michigan | Multiple-component solid phases containing at least one active pharmaceutical ingredient |
US20060052432A1 (en) * | 2002-09-20 | 2006-03-09 | Julius Remenar | Pharmaceutical compositions with improved dissolution |
RS20050390A (en) * | 2002-11-26 | 2008-04-04 | Boehringer Ingelheim Pharma Gmbh. & Co.Kg., | Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox 1/2 inhibitor |
GB0228465D0 (en) * | 2002-12-06 | 2003-01-08 | Univ Belfast | A method of treating disease |
US8183290B2 (en) | 2002-12-30 | 2012-05-22 | Mcneil-Ppc, Inc. | Pharmaceutically acceptable propylene glycol solvate of naproxen |
AT413944B (de) * | 2003-05-27 | 2006-07-15 | Binder Eva Dkfm | Verwendung von oxicam-verbindungen |
JP2007509154A (ja) * | 2003-10-21 | 2007-04-12 | ファルマシア・コーポレーション | ホスホジエステラーゼ4阻害剤と組み合わせたシクロオキシゲナーゼ−2阻害剤による呼吸器炎症のの治療または予防のための方法およびその組成物 |
US20050113410A1 (en) * | 2003-11-03 | 2005-05-26 | Mark Tawa | Pharmaceutical salts of zafirlukast |
AU2005238220A1 (en) * | 2004-04-29 | 2005-11-10 | Binder, Eva | Enantiomer-pure hexahydro- pyrrolocyclopenta- pyridine derivatives |
WO2006007095A2 (en) * | 2004-06-30 | 2006-01-19 | Albemarle Corporation | High ibuprofen content granules and their preparation and use |
US20070148245A1 (en) * | 2005-12-22 | 2007-06-28 | Ilan Zalit | Compressed solid dosage forms with drugs of low solubility and process for making the same |
CN101340896A (zh) * | 2005-12-22 | 2009-01-07 | 特瓦制药工业有限公司 | 含有低溶解性药物的压缩的固体剂型和其制备方法 |
EP1808163A1 (en) * | 2005-12-22 | 2007-07-18 | Teva Pharmaceutical Industries Ltd. | Compressed solid dosage forms with drugs of low solubility and process for making the same |
US7964182B2 (en) * | 2006-09-01 | 2011-06-21 | USV, Ltd | Pharmaceutical compositions comprising phosphate-binding polymer |
WO2008062437A2 (en) * | 2006-09-01 | 2008-05-29 | Usv Limited | Process for the preparation of sevelamer hydrochloride and formulation thereof |
RU2484132C2 (ru) * | 2007-10-08 | 2013-06-10 | Интрексон Корпорейшн | Модифицированные дендритные клетки и их применение в лечении злокачественных опухолей |
KR20110119714A (ko) * | 2009-01-22 | 2011-11-02 | 유에스브이 리미티드 | 포스페이트 결합 폴리머를 포함하는 약학적 조성물 |
CN104027319A (zh) * | 2014-06-25 | 2014-09-10 | 万特制药(海南)有限公司 | 一种塞来昔布分散片及其制备方法 |
US10350171B2 (en) | 2017-07-06 | 2019-07-16 | Dexcel Ltd. | Celecoxib and amlodipine formulation and method of making the same |
CN108057025A (zh) * | 2017-12-08 | 2018-05-22 | 佛山市弘泰药物研发有限公司 | 一种依托考昔口崩片及其制备方法 |
CN111407733A (zh) * | 2020-03-19 | 2020-07-14 | 大桐制药(中国)有限责任公司 | 一种塞莱昔布片剂的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6573290B1 (en) * | 1999-05-17 | 2003-06-03 | Ilex Oncology, Inc. | DFMO and celecoxib in combination for cancer chemoprevention and therapy |
US6395300B1 (en) * | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
NZ513964A (en) * | 1999-12-08 | 2004-01-30 | Pharmacia Corp | Solid-state form of celecoxib having enhanced bioavailability |
-
2001
- 2001-08-17 TW TW090120287A patent/TWI256305B/zh not_active IP Right Cessation
- 2001-08-17 PE PE2001000821A patent/PE20020322A1/es not_active Application Discontinuation
- 2001-08-17 AR ARP010103961A patent/AR030382A1/es unknown
- 2001-08-17 US US09/932,494 patent/US20020119193A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PE20020322A1 (es) | 2002-05-10 |
US20020119193A1 (en) | 2002-08-29 |
TWI256305B (en) | 2006-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR030382A1 (es) | Formulacion oral de un inhibidor de ciclooxigenasa-2 de fusion rapida | |
WO2002015885A3 (en) | Oral fast-melt formulation of a cyclooxygenase-2 inhibitor | |
UY26306A1 (es) | Composición para la dosificación oral, de disolución instantanea | |
GT200200125A (es) | Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco | |
BRPI0113286B8 (pt) | pirazóis substituídos e composição farmacêutica compreendendo os mesmos. | |
DK1299108T3 (da) | Parasiticidt præparat samt fremgangsmåde til fremstilling af dette præparat | |
KR850007559A (ko) | 조절 펩타이드의 삽입식 제형 | |
DE69942154D1 (de) | Medikamenthaltige zusammensetzung in aerosolform | |
ATE430560T1 (de) | Formulierung für rasche auflösung lipophiler verbindungen | |
UY27320A1 (es) | Nuevas composiciones farmacéuticas | |
WO2001058474A3 (en) | Microencapsulation and sustained release of biologically active agent | |
AR040205A1 (es) | Composicion herbicida | |
BRPI0509708B8 (pt) | espuma farmacêutica, composição de espuma de pimecrolimus contendo glicol de hexileno, opcionalmente álcool de oleil, dimetilisosorbídeo e/ou triglicerídeos de cadeia média e uso | |
PL357924A1 (en) | Composition for peroxidisingly colouring creatinefibre, containing etherocarboxylic acid, oxyalkylenated polymer capable to form associates and non-saturated fatty acid | |
DE69001535T2 (de) | Brausendes Nagelmittel. | |
AR052787A1 (es) | Proceso para preparar formulaciones de sustancias activas lipofilicas mediante liofilizacion por atomizacion | |
WO2001094543A3 (en) | Production and use of derivatized homoserine lactones | |
NL8200626A (nl) | Werkwijze voor de bereiding van bruisende farmaceutische preparaten. | |
ES2124222T3 (es) | Agentes edulcorantes de clorodesoxiazucar estabilizados en forma solida y procedimientos para su preparacion. | |
AR031206A1 (es) | Sal de perborato expandida, su uso y metodo de produccion | |
AR041334A1 (es) | Procedimiento de preparacion de composiciones de detergente en gel | |
RU99116432A (ru) | Способ иммобилизации физиологически активных соединений | |
WO2003061557A3 (en) | Levothyroxine pharmaceutical compositions, methods of making and methods of administration | |
AR034435A1 (es) | Agentes terapeuticos. | |
ES497950A0 (es) | Procedimiento para la preparacion de formulaciones fungici- das liquidas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |